Mar 17, 2023
After launching a product in the market, its manufacturing and selling are crucial for a pharmaceutical company. The companies need to balance patent expirations and new product potential to maintain high margins. We have listed top companies with an EBITDA margin of over 25% in Q3FY23. (Source: Ace Equity)
Image Source: iStock
EBITDA margin determines the company’s operating profit relative to its revenue. Hence, investors assessing it can compare the real performance of one company with another in the industry.
Image Source: THE ECONOMIC TIMES
EBITDA margin: 33%| Stock performance in last 1 year: -18%
Image Source: THE ECONOMIC TIMES
EBITDA margin: 31%| Stock performance in last 1 year: -63%
Image Source: THE ECONOMIC TIMES
EBITDA margin: 29.44%| Stock performance in last 1 year: 7%
Image Source: iStock
EBITDA margin: 29.21%| Stock performance in last 1 year: 12.68%
Image Source: THE ECONOMIC TIMES
EBITDA margin: 28.5%| Stock performance in last 1 year: -18.59%
Image Source: THE ECONOMIC TIMES
EBITDA margin: 27.06%| Stock performance in last 1 year: 6.7%
Image Source: iStock
EBITDA margin: 26.12%| Stock performance in last 1 year: -46.30%(With data inputs from Ritesh Presswala)
Image Source: THE ECONOMIC TIMES
Thanks For Reading!
Find out More